Evidence map›Paper›PMID 31205972›Full record

ArticleOpen forum infectious diseases2019

Host Determinants of Infectiousness in Smear-Positive Patients With Pulmonary Tuberculosis.

Carlos Acuña-Villaorduña, Irene Ayakaka, Luiz Guilherme Schmidt-Castellani, Francis Mumbowa, Patricia Marques-Rodrigues, Mary Gaeddert, Laura F White, Moises Palaci, Jerrold J Ellner, Reynaldo Dietze and 3 more

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Community-Based Tuberculosis Isolation Decisions Require Individualization Based on Effectiveness and Duration of Treatment, Community Risks, and Patient Harms.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Aerosol Sampling Outperforms Sputum to Predict Mycobacterium tuberculosis Transmission.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 4 countries.

Carlos Acuña-VillaorduñaSection of Infectious Diseases, Department of Medicine, Boston University School of Medicine and Boston Medical Center, Massachusetts.
Irene AyakakaMulago Hospital Tuberculosis Clinic, Mulago Hospital, Kampala, Uganda.
Luiz Guilherme Schmidt-CastellaniNúcleo de Doenças Infecciosas, Universidade Federal do Espírito Santo, Vitória, Brazil.
Francis MumbowaDepartment of Microbiology, Makerere University College of Medicine, Kampala, Uganda.
Patricia Marques-RodriguesNúcleo de Doenças Infecciosas, Universidade Federal do Espírito Santo, Vitória, Brazil.
Mary GaeddertSection of Infectious Diseases, Department of Medicine, Boston University School of Medicine and Boston Medical Center, Massachusetts.
Laura F WhiteDepartment of Biostatistics, Boston University School of Public Health, Massachusetts.
Moises PalaciNúcleo de Doenças Infecciosas, Universidade Federal do Espírito Santo, Vitória, Brazil.
Jerrold J EllnerSection of Infectious Diseases, Department of Medicine, Boston University School of Medicine and Boston Medical Center, Massachusetts.
Reynaldo DietzeNúcleo de Doenças Infecciosas, Universidade Federal do Espírito Santo, Vitória, Brazil.
Moses JolobaDepartment of Microbiology, Makerere University College of Medicine, Kampala, Uganda.
Kevin P FennellyPulmonary Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
Edward C Jones-LópezSection of Infectious Diseases, Department of Medicine, Boston University School of Medicine and Boston Medical Center, Massachusetts.
Boston Medical Center · USUniversidade Federal do Espírito Santo · BRBoston University · USMakerere University · UGMulago Hospital · UGNational Heart Lung and Blood Institute · USUniversidade Nova de Lisboa · PT

Funding

Bronchiectasis and chronic airway infectionZIAHL006200 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI FENNELLY, KEVIN · 2015 to 2025
$25.1M
Validation and Application of a Model for Human-like TB Latency in RabbitsU19AI111276 · NIAID · RBHS-NEW JERSEY MEDICAL SCHOOL · PI ALLAND, DAVID, HORSBURGH, CHARLES ROBERT · 2014 to 2020
$23.3M
US-Brazil Research Collaboration on Strain Variation in TBU01AI065663 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI ELLNER, JERROLD J. · 2005 to 2015
$5.2M
NIAID NIH HHS U01 AI065663NIAID NIH HHS U19 AI111276Wellcome Trust
6 · The paper itself

Abstract

backgroundEpidemiologic data suggests that only a minority of tuberculosis (TB) patients are infectious. Cough aerosol sampling is a novel quantitative method to measure TB infectiousness.

methodsWe analyzed data from three studies conducted in Uganda and Brazil over a 13-year period. We included sputum acid fast bacilli (AFB) and culture positive pulmonary TB patients and used a cough aerosol sampling system (CASS) to measure the number of colony-forming units (CFU) of Mycobacterium tuberculosis in cough-generated aerosols as a measure for infectiousness. Aerosol data was categorized as: aerosol negative (CFU = 0) and aerosol positive (CFU > 0). Logistic regression models were built to identify factors associated with aerosol positivity.

resultsM. tuberculosis was isolated by culture from cough aerosols in 100/233 (43%) TB patients. In an unadjusted analysis, aerosol positivity was associated with fewer days of antituberculous therapy before CASS sampling (

conclusionCough generated aerosols containing viable M. tuberculosis, the infectious moiety in TB, are detected in a minority of TB patients and rapidly become non-culturable after initiation of antituberculous treatment. Mechanistic studies are needed to further elucidate these findings.

Identifiers

PMID31205972
PMCPMC6557197
OpenAlexW2937120971

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.